Nasal administration of ketamine to manage pain
Patent 5543434 Issued on August 6, 1996. Estimated Expiration Date: 
February 25, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 25, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod for administering a dissociative, unconscious type of anesthesia Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics Pharmaceutical composition and method of intranasal administration Compositions and methods of manufacture of compressed powder medicaments Patent #: 5132114 InventorApplicationNo. 201756 filed on 02/25/1994US Classes:514/647Amino nitrogen and a ring bonded directly to the same ring and any other amino nitrogen in the compound is bonded directly to one of the ringsExaminersPrimary: Henley, III, RaymondAssistant: Spivack, Phyllis G. Attorney, Agent or FirmForeign Patent References
International ClassA61K 031/135AbstractThe invention relates to self-management of pain on an outpatient basis comprising administering via a nasal route a dose of ketamine effective to alleviate pain to a subject suffering from pain.Other References
| |
